Entasis Therapeutics Holdings Inc
NASDAQ:ETTX
Income Statement
Earnings Waterfall
Entasis Therapeutics Holdings Inc
Revenue
|
0
USD
|
Operating Expenses
|
-55.6m
USD
|
Operating Income
|
-55.6m
USD
|
Other Expenses
|
3.9m
USD
|
Net Income
|
-51.7m
USD
|
Income Statement
Entasis Therapeutics Holdings Inc
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
5
N/A
|
5
N/A
|
5
N/A
|
5
N/A
|
0
N/A
|
7
N/A
|
7
N/A
|
7
N/A
|
7
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||||||
Operating Expenses |
(31)
|
(38)
|
(42)
|
(44)
|
(43)
|
(46)
|
(48)
|
(49)
|
(54)
|
(55)
|
(55)
|
(56)
|
(54)
|
(52)
|
(51)
|
(52)
|
(52)
|
(56)
|
|
Selling, General & Administrative |
(6)
|
(8)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(12)
|
(14)
|
(14)
|
(14)
|
(14)
|
(13)
|
(13)
|
(13)
|
(14)
|
(15)
|
(17)
|
|
Research & Development |
(26)
|
(30)
|
(33)
|
(34)
|
(33)
|
(36)
|
(37)
|
(36)
|
(40)
|
(41)
|
(40)
|
(42)
|
(41)
|
(39)
|
(39)
|
(38)
|
(37)
|
(39)
|
|
Operating Income |
(31)
N/A
|
(38)
-20%
|
(37)
+1%
|
(39)
-4%
|
(38)
+2%
|
(41)
-6%
|
(48)
-17%
|
(42)
+13%
|
(47)
-13%
|
(48)
-3%
|
(48)
+1%
|
(56)
-18%
|
(54)
+3%
|
(52)
+5%
|
(51)
+0%
|
(52)
-2%
|
(52)
+0%
|
(56)
-6%
|
|
Pre-Tax Income | |||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
Total Other Income |
1
|
2
|
4
|
5
|
5
|
5
|
4
|
3
|
2
|
1
|
1
|
2
|
4
|
6
|
7
|
6
|
5
|
4
|
|
Pre-Tax Income |
(30)
N/A
|
(35)
-17%
|
(33)
+5%
|
(34)
0%
|
(32)
+3%
|
(35)
-7%
|
(43)
-23%
|
(37)
+12%
|
(43)
-15%
|
(46)
-6%
|
(46)
0%
|
(54)
-17%
|
(51)
+6%
|
(46)
+9%
|
(45)
+3%
|
(46)
-3%
|
(47)
-3%
|
(52)
-10%
|
|
Net Income | |||||||||||||||||||
Tax Provision |
0
|
0
|
(0)
|
(0)
|
0
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(30)
|
(35)
|
(34)
|
(34)
|
(33)
|
(35)
|
(43)
|
(38)
|
(44)
|
(46)
|
(46)
|
(54)
|
(51)
|
(46)
|
(45)
|
(46)
|
(47)
|
(52)
|
|
Net Income (Common) |
(30)
N/A
|
(35)
-17%
|
(34)
+3%
|
(34)
0%
|
(33)
+3%
|
(35)
-7%
|
(43)
-22%
|
(38)
+12%
|
(44)
-16%
|
(46)
-5%
|
(46)
0%
|
(54)
-17%
|
(51)
+6%
|
(46)
+9%
|
(45)
+3%
|
(46)
-3%
|
(47)
-3%
|
(52)
-10%
|
|
EPS (Diluted) |
-2.29
N/A
|
-2.69
-17%
|
-2.59
+4%
|
-2.6
0%
|
-2.47
+5%
|
-2.68
-9%
|
-3.27
-22%
|
-2.89
+12%
|
-3.31
-15%
|
-3.47
-5%
|
-2.7
+22%
|
-1.8
+33%
|
-1.41
+22%
|
-1.24
+12%
|
-1.08
+13%
|
-0.97
+10%
|
-0.99
-2%
|
-1.08
-9%
|